Cancer BiologybioRxivPreprint
Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity
J. D. Kratz, S. Rehman, K. A. Johnson…·D. A. Deming
The paper evaluates individual patient-derived cancer organoids using optical metabolic imaging to predict therapeutic response and identify subclonal populations and resistance mechanisms.
DOI 10.1101/2021.10.15.464556